Skip to main content

Flexible Cystoscope

Steerable 15–17 Fr endoscope with two-way distal tip deflection — the workhorse for office-based diagnostic cystoscopy under topical anesthesia and the most commonly performed procedure in urology (> 1 million / year in the US, 2009–2015). Three optical generations: fiberoptic → standard-definition digital → high-definition digital (chip-on-tip), now joined by single-use disposable digital scopes. First applied 1973, purpose-built 1984.[1][2][3][4]

Design​

ComponentDetail
OpticsFiberoptic (coherent glass-fiber bundle, lower resolution) or digital chip-on-tip (distal CMOS / CCD sensor); HD digital is significantly superior in resolution, contrast, color, and depth of field[5][6][7]
Outer diameter15–17 Fr (5.0–5.7 mm) — about half the caliber of the operative rigid cystoscope
Working channel≥ 6 Fr (2.0 mm) — biopsy forceps, graspers, laser fibers (365–600 μm), guidewires, ureteral catheters
Tip deflection180°–230° up / 95°–220° down via thumb lever; digital scopes typically deflect further
Length~ 35–40 cm — sufficient for male and female anatomy
Field of view~ 120°
IrrigationGravity-fed saline or sterile water through the working channel; flow falls when an instrument is passed

HD digital cystoscope resolution 14.3 lp/mm at 10 mm vs 4.00 (SD digital) vs 2.24 (fiberoptic), p < 0.001; in a 1,022-case head-to-head, surgeons preferred digital for optics, deflection, and overall performance (all p < 0.01).[5][6]

Reconstructive-Urology and Urogyn Uses​

Diagnostic​

  • Hematuria workup — all gross hematuria and intermediate / high-risk microhematuria per AUA/SUFU 2025.[8]
  • NMIBC surveillance — the dominant office modality.[9][8][10]
  • Recurrent UTI in postmenopausal women — Ordonez 2022 found abnormal flexible-cystoscopy findings in 74% (trigonitis 67% most common).[11]
  • LUTS / pelvic-pain workup — clinically relevant findings in 11.5% of patients investigated for profound LUTS / recurrent UTI / pain.[12]
  • Intraoperative ureteral patency assessment after prolapse repair, hysterectomy, sacrocolpopexy, fistula repair — see AUGS 2018 consensus on cystoscopy at prolapse repair.[13]
  • Mesh-erosion / -exposure surveillance after MUS or transvaginal mesh; retroflexion reaches the bladder neck and anterior wall — a key advantage over the rigid cystoscope for these locations.[3]
  • Difficult catheterization / failed urethral access — bedside flexible cystoscopy with guidewire-assisted catheter placement (Beaghler 1994 paradigm) has largely replaced the filiform-and-follower approach wherever a flexible scope is available.

Therapeutic (in-office, working-channel)​

  • Ureteral stent removal — one of the most common office indications; grasper-integrated single-use platforms (Ambu aScope, Pusen) specifically designed for this.[14][15]
  • Small bladder-tumor fulguration with Nd:YAG / holmium fiber.
  • Ureteral catheter / guidewire placement prior to OR stenting or before ESWL.
  • Foreign-body retrieval via grasper.
  • DVIU of small distal strictures with laser fiber.
  • Botulinum-toxin intradetrusor injection in selected office workflows.

Technique — Office Flexible Cystoscopy​

  1. Position — supine (men, legs flat or slightly apart) or frog-leg supine (women); dorsal lithotomy not required.[1]
  2. Sterile prep; instil 2% lidocaine gel intraurethrally — Raskolnikov 2019 meta of 12 RCTs (n = 1,549) showed significant pain reduction with lidocaine vs plain lubricant (SMD −0.22, 95% CI −0.39 to −0.05), particularly with longer dwell times.[16]
  3. No benefit from a 3-min "dwell" delay vs immediate insertion (Losco 2011 RCT).[17]
  4. Pass under direct vision — penis at ~ 60° in males to straighten the urethra; navigate penile → bulbar → membranous → prostatic → bladder neck.
  5. Distend with irrigant; systematic inspection — trigone → ureteral orifices (confirm bilateral efflux) → posterior / lateral / dome / anterior walls; retroflex to inspect bladder neck and anterior wall.

Flexible vs Rigid Cystoscopy​

FeatureFlexibleRigid
OpticsFiberoptic or digital chip-on-tipHopkins rod-lens (superior at the high end)
Caliber15–17 Fr17–26 Fr
Tip deflection / retroflexionYes — 180°+None — requires 70° / 120° lens swap
Pain — men~ 3× less (Krajewski 2017; Seklehner 2015 58.7% vs 24% pain-free)More painful
Pain — womenNo significant difference vs rigid (Quiroz 2012, Rappaport 2020)Comparable
AnesthesiaTopical lidocaine gelLocal for diagnostic; regional / GA for operative
PositionSupine / frog-legDorsal lithotomy
Operative capabilityLimited (biopsy, fulguration, stent removal)Full — TURBT, resection, large instruments
ReprocessingHigh-level disinfection or single-use disposableHigh-level disinfection

Single-Use vs Reusable Flexible Cystoscopes — The Modern Decision​

Single-use digital flexible cystoscopes are now a major segment:

  • Holmes 2023 RCT (n = 101, noninferiority) — Ambu aScope 4 Cysto vs Olympus CYF-VH: noninferior completion 100% vs 98%, image quality 96% vs 100%, light 98% vs 100%, maneuverability 98% vs 100%.[18]
  • Seyam 2020 (n = 1,211) — cancer-detection rate equivalent: 14.4% disposable vs 15.6% reusable (p = 0.574).[14]
  • Anderson 2024 SR (21 studies, n = 3,943) — no difference in postoperative infection (4.0% vs 4.4%, p = 0.87) or overall complications (11.5% vs 11.9%, p = 0.88).[19]
  • Per-case cost (Assmus 2022 tertiary center) — $185 single-use vs $272 reusable; ~ $39K / yr savings with predominantly single-use scopes.[20]
  • Cost-effectiveness is volume-dependent — reusable scopes become more economical above ~ 350 procedures / 10 scopes; single-use favored at lower volumes or for specific procedures (eg, stent removal).[15][21]
  • Environmental — single-use generates less waste / procedure (200 g vs 800 g) and eliminates ~ 60 L water / procedure for sterilization.[22]

Enhanced Imaging — In the Office​

  • Blue-light flexible cystoscopy (HAL-PDD) — Daneshmand 2018 phase-III multicenter trial: detected recurrence missed by white light in 20.6% (13/63), p < 0.01.[10] Sari Motlagh 2024 surveillance meta found no significant overall recurrence-detection difference vs WLC (OR 1.08, 95% CI 0.82–1.41); NNT ~ 100.[23]
  • Narrow-band imaging (NBI) — sensitivity 87.8–100% vs ~ 67% for white light (Ye 2015 multicenter RCT 97.7% vs 66.7%, p < 0.05).[24][25] AUA/SUO 2024 amendment acknowledges NBI availability and no added risk, without yet proving recurrence reduction.[26]

Antibiotic Prophylaxis​

The AUA Best Practice Statement recommends against routine antibiotic prophylaxis for simple outpatient flexible cystoscopy in healthy adults without active infection — baseline post-cystoscopy UTI ~ 3% in placebo arms.[27] Cochrane (Zeng 2019) found prophylaxis unlikely to reduce symptomatic UTI (RR 0.59, 95% CI 0.32–1.10, p = 0.10).[28] EAU also recommends against routine prophylaxis for any cystoscopy.

Limitations​

  • No operative capability for resection — TURBT, BNI, full DVIU require the rigid scope / resectoscope and Sachse urethrotome.
  • Reduced visualization in active bleeding — large clot burden obscures the view; switch to rigid for clot evacuation.
  • Smaller working channel — limits instrument size and reduces irrigation flow when an instrument is passed.
  • Fiberoptic image quality inferior to rod-lens — digital chip-on-tip has largely closed this gap.
  • Cumbersome drainage — withdrawing irrigant or draining the bladder is awkward vs a rigid sheath.

See also: Rigid Cystoscope, Sachse Urethrotome, Guidewires, Open-Ended Ureteral Catheters, Double-J Stent, Filiforms & Followers.

References​

1. Safiullah S, Lama DJ, Patel R, Clayman RV. "Procedural module: flexible cystoscopy." J Endourol. 2018;32(S1):S2–6. doi:10.1089/end.2017.0706

2. Kennedy TJ, Preminger GM. "Flexible cystoscopy." Urol Clin North Am. 1988;15(3):525–8.

3. Kavoussi LR, Clayman RV. "Office flexible cystoscopy." Urol Clin North Am. 1988;15(4):601–8.

4. Grasso M, Beaghler M, Bagley DH, Strup S. "Actively deflectable, flexible cystoscopes: no longer solely a diagnostic instrument." J Endourol. 1993;7(6):527–30. doi:10.1089/end.1993.7.527

5. Okhunov Z, Hruby GW, Mirabile G, et al. "Prospective comparison of flexible fiberoptic and digital cystoscopes." Urology. 2009;74(2):427–30. doi:10.1016/j.urology.2009.01.007

6. Lusch A, Liss MA, Greene P, et al. "Comparison of optics and performance of a distal sensor high definition cystoscope, a distal sensor standard definition cystoscope, and a fiberoptic cystoscope." Urology. 2013;82(6):1226–30. doi:10.1016/j.urology.2013.06.033

7. Borin JF, Abdelshehid CS, Clayman RV. "Comparison of resolution, contrast, and color differentiation among fiberoptic and digital flexible cystoscopes." J Endourol. 2006;20(1):54–8. doi:10.1089/end.2006.20.54

8. Barocas DA, Lotan Y, Matulewicz RS, et al. "Updates to microhematuria: AUA/SUFU guideline (2025)." J Urol. 2025;213(5):547–57. doi:10.1097/JU.0000000000004490

9. Lenis AT, Lec PM, Chamie K, Mshs MD. "Bladder cancer: a review." JAMA. 2020;324(19):1980–91. doi:10.1001/jama.2020.17598

10. Daneshmand S, Patel S, Lotan Y, et al. "Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter study." J Urol. 2018;199(5):1158–65. doi:10.1016/j.juro.2017.11.096

11. Ordonez J, Christie AL, Zimmern PE. "Role of flexible cystoscopy in the management of postmenopausal women with recurrent urinary tract infections." Urology. 2022;169:65–9. doi:10.1016/j.urology.2022.07.040

12. Howles S, Tempest H, Doolub G, et al. "Flexible cystoscopy findings in patients investigated for profound lower urinary tract symptoms, recurrent urinary tract infection, and pain." J Endourol. 2012;26(11):1468–72. doi:10.1089/end.2012.0139

13. Cohen SA, Carberry CL, Smilen SW. "American Urogynecologic Society consensus statement: cystoscopy at the time of prolapse repair." Female Pelvic Med Reconstr Surg. 2018;24(4):258–9. doi:10.1097/SPV.0000000000000529

14. Seyam RM, Zeitouni OM, Alsibai TM, et al. "The grasper-integrated disposable flexible cystoscope is comparable to the reusable, flexible cystoscope for the detection of bladder cancer." Sci Rep. 2020;10(1):13495. doi:10.1038/s41598-020-70424-0

15. Su ZT, Huang MM, Matlaga BR, Hutfless S, Koo K. "A micro-costing analysis of outpatient flexible cystoscopy: implications for adoption of single-use flexible cystoscopes." World J Urol. 2021;39(11):4275–81. doi:10.1007/s00345-021-03724-3

16. Raskolnikov D, Brown B, Holt SK, et al. "Reduction of pain during flexible cystoscopy: a systematic review and meta-analysis." J Urol. 2019;202(6):1136–42. doi:10.1097/JU.0000000000000399

17. Losco G, Antoniou S, Mark S. "Male flexible cystoscopy: does waiting after insertion of topical anaesthetic lubricant improve patient comfort?" BJU Int. 2011;108 Suppl 2:42–4. doi:10.1111/j.1464-410X.2011.10696.x

18. Holmes A, O'Kane D, Wombwell A, Grills R. "Clinical utility of a single-use flexible cystoscope compared with a standard reusable device: a randomized noninferiority study." J Endourol. 2023;37(1):80–4. doi:10.1089/end.2022.0210

19. Anderson S, Patterson K, Skolarikos A, et al. "Perspectives on technology: to use or to reuse, that is the endoscopic question — a systematic review of single-use endoscopes." BJU Int. 2024;133(1):14–24. doi:10.1111/bju.16206

20. Assmus MA, Krambeck AE, Lee MS, et al. "Cost-effectiveness of 90-day single-use flexible cystoscope trial: single center micro-costing analysis and user satisfaction." Urology. 2022;167:61–6. doi:10.1016/j.urology.2022.05.039

21. Foo JCH, Lim EJ, Lee SZ, Yong J. "To throw, or not to throw: threshold cost analysis of the single-use flexible cystoscopy model in a high-volume urology centre." ANZ J Surg. 2025. doi:10.1111/ans.70451

22. Boucheron T, Lechevallier E, Gondran-Tellier B, et al. "Cost and environmental impact of disposable flexible cystoscopes compared to reusable devices." J Endourol. 2022;36(10):1317–21. doi:10.1089/end.2022.0201

23. Sari Motlagh R, Ghoreifi A, Yanagisawa T, et al. "Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis." BJU Int. 2024;134(4):526–33. doi:10.1111/bju.16364

24. Remmelink MJ, Rip Y, Nieuwenhuijzen JA, et al. "Advanced optical imaging techniques for bladder cancer detection and diagnosis: a systematic review." BJU Int. 2024;134(6):890–905. doi:10.1111/bju.16471

25. Ye Z, Hu J, Song X, et al. "A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: a prospective, randomized and multi-center study." Sci Rep. 2015;5:10905. doi:10.1038/srep10905

26. Holzbeierlein JM, Bixler BR, Buckley DI, et al. "Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline 2024 amendment." J Urol. 2024;211(4):533–8. doi:10.1097/JU.0000000000003846

27. Lightner DJ, Wymer K, Sanchez J, Kavoussi L. "Best practice statement on urologic procedures and antimicrobial prophylaxis." J Urol. 2020;203(2):351–6. doi:10.1097/JU.0000000000000509

28. Zeng S, Zhang Z, Bai Y, Sun Y, Xu C. "Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy." Cochrane Database Syst Rev. 2019;2:CD012305. doi:10.1002/14651858.CD012305.pub2